- Home
- MCRB vs MLSS Comparison
MCRB vs MLSS Comparison
Compare MCRB & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- MLSS
- Stock Information
- Founded
- MCRB 2010
- MLSS 1989
- Country
- MCRB United States
- MLSS United States
- Employees
- MCRB N/A
- MLSS N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- MCRB Health Care
- MLSS Health Care
- Exchange
- MCRB Nasdaq
- MLSS Nasdaq
- Market Cap
- MCRB 81.2M
- MLSS 74.5M
- IPO Year
- MCRB 2015
- MLSS 1995
- Fundamental
- Price
- MCRB $7.06
- MLSS $0.96
- Analyst Decision
- MCRB Hold
- MLSS Buy
- Analyst Count
- MCRB 5
- MLSS 1
- Target Price
- MCRB $73.67
- MLSS $1.25
- AVG Volume (30 Days)
- MCRB 146.8K
- MLSS 53.4K
- Earning Date
- MCRB 05-07-2025
- MLSS 05-19-2025
- Dividend Yield
- MCRB N/A
- MLSS N/A
- EPS Growth
- MCRB N/A
- MLSS N/A
- EPS
- MCRB 0.03
- MLSS N/A
- Revenue
- MCRB N/A
- MLSS $8,629,928.00
- Revenue This Year
- MCRB N/A
- MLSS $29.14
- Revenue Next Year
- MCRB N/A
- MLSS $20.19
- P/E Ratio
- MCRB $213.09
- MLSS N/A
- Revenue Growth
- MCRB N/A
- MLSS N/A
- 52 Week Low
- MCRB $7.18
- MLSS $0.58
- 52 Week High
- MCRB $30.60
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- MCRB 33.07
- MLSS 49.61
- Support Level
- MCRB $8.92
- MLSS $0.89
- Resistance Level
- MCRB $9.97
- MLSS $1.05
- Average True Range (ATR)
- MCRB 1.08
- MLSS 0.07
- MACD
- MCRB -0.06
- MLSS 0.00
- Stochastic Oscillator
- MCRB 10.61
- MLSS 34.78
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.